These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 21494607)

  • 1. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.
    Burridge PW; Thompson S; Millrod MA; Weinberg S; Yuan X; Peters A; Mahairaki V; Koliatsos VE; Tung L; Zambidis ET
    PLoS One; 2011 Apr; 6(4):e18293. PubMed ID: 21494607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes.
    Burridge PW; Zambidis ET
    Methods Mol Biol; 2013; 997():149-61. PubMed ID: 23546754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF.
    Ye L; Zhang S; Greder L; Dutton J; Keirstead SA; Lepley M; Zhang L; Kaufman D; Zhang J
    PLoS One; 2013; 8(1):e53764. PubMed ID: 23326500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and Characterization of Patient-Specific iPSC Model for Cardiovascular Disease.
    Lee YK; Ran X; Lai KW; Lau VY; Siu DC; Tse HF
    Methods Mol Biol; 2016; 1353():191-213. PubMed ID: 26126449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized conditions for the supplementation of human-induced pluripotent stem cell cultures with a GSK-3 inhibitor during embryoid body formation with the aim of inducing differentiation into mesodermal and cardiac lineage.
    Yoda K; Ohnuki Y; Masui S; Kurosawa H
    J Biosci Bioeng; 2020 Mar; 129(3):371-378. PubMed ID: 31615734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells.
    Ren Y; Lee MY; Schliffke S; Paavola J; Amos PJ; Ge X; Ye M; Zhu S; Senyei G; Lum L; Ehrlich BE; Qyang Y
    J Mol Cell Cardiol; 2011 Sep; 51(3):280-7. PubMed ID: 21569778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.
    Hwang GH; Park SM; Han HJ; Kim JS; Yun SP; Ryu JM; Lee HJ; Chang W; Lee SJ; Choi JH; Choi JS; Lee MY
    J Cell Physiol; 2017 Dec; 232(12):3384-3395. PubMed ID: 28063225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells.
    Cao N; Liu Z; Chen Z; Wang J; Chen T; Zhao X; Ma Y; Qin L; Kang J; Wei B; Wang L; Jin Y; Yang HT
    Cell Res; 2012 Jan; 22(1):219-36. PubMed ID: 22143566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells.
    Weng Z; Kong CW; Ren L; Karakikes I; Geng L; He J; Chow MZ; Mok CF; Chan HYS; Webb SE; Keung W; Chow H; Miller AL; Leung AY; Hajjar RJ; Li RA; Chan CW
    Stem Cells Dev; 2014 Jul; 23(14):1704-16. PubMed ID: 24564569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer and scalable 3D suspension bioreactor cultures with reduced batch-to-batch variations.
    Hamad S; Derichsweiler D; Papadopoulos S; Nguemo F; Šarić T; Sachinidis A; Brockmeier K; Hescheler J; Boukens BJ; Pfannkuche K
    Theranostics; 2019; 9(24):7222-7238. PubMed ID: 31695764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
    Ojala M; Rajala K; Pekkanen-Mattila M; Miettinen M; Huhtala H; Aalto-Setälä K
    PLoS One; 2012; 7(10):e48659. PubMed ID: 23119085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering.
    Lim SY; Sivakumaran P; Crombie DE; Dusting GJ; Pébay A; Dilley RJ
    Stem Cells Transl Med; 2013 Sep; 2(9):715-25. PubMed ID: 23884641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee YK; Ng KM; Lai WH; Chan YC; Lau YM; Lian Q; Tse HF; Siu CW
    Stem Cell Rev Rep; 2011 Nov; 7(4):976-86. PubMed ID: 21614516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies.
    Hatani T; Miki K; Yoshida Y
    Methods Mol Biol; 2018; 1816():79-92. PubMed ID: 29987812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A.
    Lim SY; Sivakumaran P; Crombie DE; Dusting GJ; Pébay A; Dilley RJ
    Methods Mol Biol; 2016; 1357():415-21. PubMed ID: 25520285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The L-type Ca2+ channels blocker nifedipine represses mesodermal fate determination in murine embryonic stem cells.
    Nguemo F; Fleischmann BK; Gupta MK; Sarić T; Malan D; Liang H; Pfannkuche K; Bloch W; Schunkert H; Hescheler J; Reppel M
    PLoS One; 2013; 8(1):e53407. PubMed ID: 23320083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.